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Aim: We have previously shown that body mass index (BMI) and 
measures of body composition and fat distribution are associ- 
ated with radiographic knee OA, but whether these measures are 
associated with knee symptoms severity is unknown. The pur- 
pose of this analysis is to explore the associations between BMI, 
measures of body composition (fat mass, lean mass, and bone 
mass), and measures of fat distribution (waist-to-hip ratio and 
waist circumference) and knee symptoms everity, and to deter- 
mine whether these relationships are modified by ethnicity. 
Methods: Data were from a subset of women (n = 756, 27.5% 
African-American) aged 45 and older enrolled in the John- 
ston County Osteoarthritis Project who had available knee ra- 
diographs, full body dual-energy x-ray absorptiometry (DEXA) 
scans, and information on knee symptoms (pain, aching, or stiff- 
ness on most days in at least one knee). Six separate propor- 
tional odds models were used to examine associations between 
knee symptoms severity (none, mild, moderate, or severe) and 
BMI, body composition, and fat distribution variables, modeled in 
quartiles with adjusted odds ratios and 95% confidence intervals 
[aOR (95% CI)] calculated comparing the fourth to first quartiles. 
All models were adjusted for age, ethnicity, prior joint injury, type 
of DEXA scanner, and Kellgren-Lawrence radiographic grade. 
Interactions between exposure variables and ethnicity (African- 
American/Caucasian) were assessed. 
Results: Mean (SD) age was 64.6 years (9.3) and BMI 30.2 
(6.3). Of the 356 (47.1%) individuals who reported knee symp- 
toms, 37.9%, 40.7%, and 21.3% reported mild, moderate, or se- 
vere symptoms, respectively. Adjusted models showed that BMI 
[aOR=2.41 (1.58, 3.69)], fat mass [aOR=2.11 (1.38, 3.21)], and 
waist circumference [aOR=1.79 (1.18, 2.70)] were associated 
with greater cumulative odds of having more severe knee symp- 
toms. Lean mass [aOR=1.36 (0.85, 2.19)], bone mass [aOR=1.17 
(0.70, 1.95)], and waist-to-hip ratio [aOR=1.14 (0.75, 1.74)] were 
not strongly associated with more severe symptoms. No signifi- 
cant interactions were found between BMI, body composition, or 
fat distribution measures and ethnicity. 
Conclusions: In contrast to the associations with radiographic 
knee OA, increased lean mass and bone mass tend not to be as- 
sociated with more severe knee symptoms. However, increased 
BMI, fat mass, and waist circumference are associated with more 
severe knee symptoms, independently of radiographic severity, 
in both African-American and Caucasian women. This suggests 
that the adiposity component of body composition may be more 
relevant o knee symptoms everity than either lean or bone com- 
ponents, and that interventions targeting adiposity should be em- 
phasized to reduce the burden of knee symptoms in women. 
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Background: Several studies have shown an increase in Insulin- 
like growth factor (IGF) binding protein 3 (IGFBP-3) in intact 
osteoarthritic (OA) cartilages and/or cultured OA chondrocytes. 
IGFBP-3 is a pleitropic protein that can act by modulating IGF 
signaling via the IGF-I receptor or via IGF independent routes, 
and its mechanism of action in articular cartilage is unknown. 
Goals: (1) To evaluate the relationship between IGFBP-3 and 
IGF-I levels in extracts of human cartilage derived from donors 
with different degrees of OA, and (2) to determine the localization 
of IGFBP-3 in normal and OA cartilage. 
Methods: Human cartilage was dissected from femoral heads 
derived from arthroplasty for OA; severely fibrillated tissues were 
pooled together, as were mildy-fibrillated and intact areas. All 
samples (n=17) were evaluated for OA stage by the histological 
criteria of Mankin. Cartilage extracts were prepared from fresh 
cartilage samples by stirring in buffers containing 8 M urea, and 
the extracts depleted of proteoglycans by DEAE chromatography. 
Total IGF-I was evaluated by ELISA after removal of binding pro- 
teins by acid-ethanol extraction, and IGFBP-3 was also evaluated 
by ELISA (DSLabs). Western Ligand Blots used 1251-1GF-II as the 
probe. Immunohistochemistry was performed on paraffin embed- 
ded sections using polyclonal anti-IGFBP-3 (Upstate). 
Results: Normal to mildy degenerated cartilage (scores 0-3) had 
a mean 2.9 4- 1.7 ng IGF-I/mg protein (n=6) and OA cartilage 
(scores > 3) had a mean 3.4 4- 1.7 (n=11). The correlation of 
IGF-I to OA group was not statistically significant. IGFBP-3 was 
measured in the same samples and the molar ratios of IGF-I to 
IGFBP-3 were calculated. Most of the samples (n=10) had ratios 
>1, indicating an excess of the IGF-I ligand. Two way ANOVA 
indicated that there were no significant effects between the IGF- 
I to IGFBP-3 molar ratio and OA group. Western ligand blots of 
chondrocyte lysates from 2 of the samples showed a stronger 
signal for IGFBP-3 than the corresponding extracts from intact 
cartilage (same protein loads). Immunohistochemistry showed a 
strong intracellular IGFBP-3 signal for a set of 3 samples with mild 
(score=l), intermediate (score=6) and severe OA (score=10). 
High resolution imaging indicated that most of the signal was in 
the cell nucleus, although a web-like cytoplasmic pattern was also 
noted. The radial zone of normal cartilage was negative, while all 
zones in OA cartilage were positive. Controls prepared without 
primary antibody or epitope blocked antibody were all negative. 
Conclusions: The excess of IGF-I over IGFBP-3 in OA cartilage 
and the predominantly nuclear localization of IGFBP-3 strongly 
suggest that the action of IGFBP-3 is independent of IGF-I re- 
ceptor signaling. This suggests the hypothesis that IGFBP-3 acts 
directly through gene regulation of chondrocytes. 
Acknowledgement: This work was supported by NIH grant R01 
AR48304. 
